Related Experiment Video
Updated: Feb 28, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Initiation of Tertiary Lymphoid Structures for Cancer Immunotherapy.
Ji-Yuan Zou1, Ze-Tong Li1, Ze-Cheng Wang1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
Tertiary lymphoid structures (TLSs) initiation is crucial for effective antitumor immunity. Understanding these immune cell aggregates in tumor microenvironments (TMEs) can guide new cancer immunotherapy strategies.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Tertiary lymphoid structures (TLSs) are organized immune cell aggregates found in chronic inflammation and tumor microenvironments (TMEs).
- TLS initiation is a critical early step for developing an effective antitumor immune response.
- The formation of TLSs involves complex interactions between various immune cells and signaling molecules.
Purpose of the Study:
- To systematically review the key triggers and signaling pathways involved in TLS initiation.
- To elucidate the role of TLSs in reshaping the TME and enhancing antitumor immunity.
- To discuss strategies for modulating TLS initiation and their potential in cancer immunotherapy.
Main Methods:
- Systematic literature review of studies on TLS initiation.
- Analysis of signaling networks and cellular interactions driving TLS formation.
- Discussion of experimental and clinical data related to TLS modulation.
Main Results:
- TLS initiation is driven by specific cytokines and chemokines, involving lymphoid tissue inducer and organizer cells.
- TLSs effectively reshape the TME, improve antigen presentation, and recruit immune cells.
- Modulating TLS initiation presents a promising avenue for enhancing cancer immunotherapy efficacy.
Conclusions:
- TLS initiation is a key determinant of antitumor immune responses.
- Targeting TLS formation offers a novel strategy for improving cancer treatments.
- Further research into TLS biology is essential for advancing cancer immunotherapy.
More Related Videos
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
10:44A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Cells of the Adaptive Immune Response
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...